Frontiers in Psychiatry | Psychopharmacology

Case Report

Published on 23 Sep 2025

A case report of seizure worsening after perampanel add-on to oxcarbazepine: possible role of metabolic interaction and pharmacogenetics

in Psychopharmacology

Xin Fang
Menglu Zhu
Lijiang Wang

Frontiers in Psychiatry

doi 10.3389/fpsyt.2025.1621598

2,303 views
1 citation

Systematic Review

Published on 22 Sep 2025

Reporting of harms in systematic reviews focused on naltrexone: a cross-sectional study

in Psychopharmacology

Joseph Schnitker
Lindsey Purcell
Morgan Garrett
Holly Flores
Audrey Wise
Micah Kee
Brayden Rucker
Adam Khan
Jason Beaman
Matt Vassar

Frontiers in Psychiatry

doi 10.3389/fpsyt.2025.1597019

2,004 views

Perspective

Published on 22 Sep 2025

The collective lie in ketamine therapy: a call to realign clinical practice with neurobiology

in Psychopharmacology

Charles Miller
Bryan Lopes
Anna McCurdy

Frontiers in Psychiatry

doi 10.3389/fpsyt.2025.1610335

3,733 views

Original Research

Published on 17 Sep 2025

Changes in self-reported alcohol consumption at high and low consumption in the wake of the COVID-19 pandemic: a test of the polarization hypothesis

in Psychopharmacology

Alexander Tran
Huan Jiang
Shannon Lange
Mindaugas Štelemėkas
Daumantas Stumbrys
Ilona Tamutienė
Jürgen Rehm

Frontiers in Psychiatry

doi 10.3389/fpsyt.2025.1516090

2,057 views

Original Research

Published on 12 Sep 2025

Medication adherence in obsessive-compulsive disorders and evaluation of effective adherence support strategies

in Psychopharmacology

Sophia Pöppel
Sina Ziegler
Klara Bednasch
Elisabeth Kohls
Christine Rummel-Kluge

Frontiers in Psychiatry

doi 10.3389/fpsyt.2025.1642622

2,916 views

Correction

Published on 11 Sep 2025

Correction: Therapeutic and legal aspects of psilocybin in cancer-related depression

in Psychopharmacology

Małgorzata Wierzbicka
Renata Kopczyk
Aleksandra Gerlach
Joanna Rymaszewska

Frontiers in Psychiatry

doi 10.3389/fpsyt.2025.1698185

1,417 views

Hypothesis and Theory

Published on 09 Sep 2025

A framework for safe estradiol modulation in male bipolar disorder: theoretical justification for SERM-enabled adjunctive therapy

in Psychopharmacology

John Carlson

Frontiers in Psychiatry

doi 10.3389/fpsyt.2025.1644175

3,161 views
1 citation

Clinical Trial

Published on 02 Sep 2025

Mindfulness, music, visual occlusion in ketamine therapy for depression: do they change outcomes? A qualitative and quantitative analysis of a randomized controlled trial

in Psychopharmacology

Mina Kheirkhah
Nastasia McDonald
Julia Aepfelbacher
Manivel L. Rengasamy
Sharvari Shivanekar
Crystal Spotts
Iya Cooper
Andrew Baumeister
Elizabeth Bell
Kevin Do-Nguyen

Frontiers in Psychiatry

doi 10.3389/fpsyt.2025.1642025

3,376 views

Perspective

Published on 01 Sep 2025

Psychedelic therapy: bridging neuroplasticity, phenomenology, and clinical outcomes

in Psychopharmacology

Ronit Kishon
Yael M. Cycowicz

Frontiers in Psychiatry

doi 10.3389/fpsyt.2025.1637162

4,170 views

Review

Published on 01 Sep 2025

Optimizing long-acting injectable antipsychotic safety and care continuity through documentation best practices

in Psychopharmacology

Amie R. Throneberry
Bradley G. Burk
Brandon S. Pruett

Frontiers in Psychiatry

doi 10.3389/fpsyt.2025.1659290

3,490 views
1 citation

Case Report

Published on 28 Aug 2025

Case Report: Clinical pharmacist prescriber in depression treatment in primary care settings: clinical case focused on prescribing practice

in Psychopharmacology

Matej Stuhec

Frontiers in Psychiatry

doi 10.3389/fpsyt.2025.1677152

2,370 views
1 citation

Original Research

Published on 28 Aug 2025

Pharmacist-assisted implementation of guideline recommendations for QTc monitoring during psychopharmacotherapy - a prospective, randomized feasibility study

in Psychopharmacology

Katharina Wien
Jan Philipp Klein
Niels Rodenstein
Julia Vogler
Roland Richard Tilz
Julia Thern
Stefan Borgwardt

Frontiers in Psychiatry

doi 10.3389/fpsyt.2025.1606497

1,449 views

Opinion

Published on 26 Aug 2025

Psychedelic minimalism: the case against music in psychedelic therapy settings

in Psychopharmacology

Samir A Nader

Frontiers in Psychiatry

doi 10.3389/fpsyt.2025.1652568

2,546 views

Original Research

Published on 15 Aug 2025

Post marketing safety assessment of the novel postpartum depression drug, Zuranolone: evidence from real-world pharmacovigilance analysis based on the FDA adverse event reporting system

in Psychopharmacology

Duoqin Huang
Zixin Luo
Xi Gong
Kang Zou
Yu Peng
Shaoying Zeng

Frontiers in Psychiatry

doi 10.3389/fpsyt.2025.1517773

3,754 views

Original Research

Published on 08 Aug 2025

Better treatment outcomes with aripiprazole long-acting injection in community and incarcerated patients with serious mental illness

in Psychopharmacology

Erasmia I. Koiliari
Ioannis Mouzas
Georgios Alevizopoulos
Otto Lesch
Henriette Walter
Emmanouil L. Pasparakis

Frontiers in Psychiatry

doi 10.3389/fpsyt.2025.1499400

2,661 views

Review

Published on 08 Aug 2025

New and emerging pharmacologic treatments for MDD

in Psychopharmacology

Aslihan Uyar
Ali Saffet Gonul

Frontiers in Psychiatry

doi 10.3389/fpsyt.2025.1621887

7,087 views
1 citation

Brief Research Report

Published on 07 Aug 2025

Effects of adjunctive brexpiprazole in patients with major depressive disorder and sleep disturbance: a post hoc analysis of three randomized trials

in Psychopharmacology

Ferhat Ardic
Zhen Zhang
Michael Hogan

Frontiers in Psychiatry

doi 10.3389/fpsyt.2025.1618176

3,232 views
2 citations

Original Research

Published on 06 Aug 2025

Improved mental health outcomes and normalised spontaneous EEG activity in veterans reporting a history of traumatic brain injuries following participation in a psilocybin retreat

in Psychopharmacology

Grace Blest-Hopley
Giuseppe Pasculli
Simon G. D. Ruffell
WaiFung Tsang
Olateju Emmanuel
Kathryn M. Pate
Hannes Kettner
Leor Roseman
David Erritzoe
Robin Carhart-Harris

Frontiers in Psychiatry

doi 10.3389/fpsyt.2025.1594307

6,073 views

Case Report

Published on 05 Aug 2025

Successful treatment of PGAD/GPD with leuprolide: a case report

in Psychopharmacology

Wang Rong
Hongwen Zhou
Hongqi Fan

Frontiers in Psychiatry

doi 10.3389/fpsyt.2025.1623256

2,419 views

Hypothesis and Theory

Published on 04 Aug 2025

Therapeutic and legal aspects of psilocybin in cancer-related depression

in Psychopharmacology

Małgorzata Wierzbicka
Renata Kopczyk
Aleksandra Gerlach
Joanna Rymaszewska

Frontiers in Psychiatry

doi 10.3389/fpsyt.2025.1591864

2,337 views

Review

Published on 30 Jul 2025

The impact of ketamine on cognitive outcomes in geriatric anesthesia: a comprehensive review

in Psychopharmacology

Shuyong You
Zhaohui Li

Frontiers in Psychiatry

doi 10.3389/fpsyt.2025.1594730

4,088 views

Systematic Review

Published on 15 Jul 2025

Exploration of current situation of psychotropic drugs research and development in China based on drug clinical trials

in Psychopharmacology

Chen Xu
Yang Zhao
Xueqin Yang
Juan Zheng
Qian Tang

Frontiers in Psychiatry

doi 10.3389/fpsyt.2025.1599038

3,082 views
1 citation

Case Report

Published on 15 Jul 2025

Clomipramine potentially induced fatal torsades de pointes in a patient with acute decompensated heart failure: a case report

in Psychopharmacology

Rong-Hua Wang
Yu-Liang Lu
Jia-Hui Lu

Frontiers in Psychiatry

doi 10.3389/fpsyt.2025.1595211

2,493 views
2 citations

Case Report

Published on 10 Jul 2025

Case Report: I want more olanzapine: pharmacogenetic insights into a patient's preference for high-dose olanzapine

in Psychopharmacology

Liam Korošec Hudnik
Ivo Kosmačin
Tanja Blagus
Vita Dolžan
Jurij Bon
Milica Pjevac

Frontiers in Psychiatry

doi 10.3389/fpsyt.2025.1633198

2,814 views
2 citations

609 articles

articles

A case report of seizure worsening after perampanel add-on to oxcarbazepine: possible role of metabolic interaction and pharmacogenetics

Reporting of harms in systematic reviews focused on naltrexone: a cross-sectional study

The collective lie in ketamine therapy: a call to realign clinical practice with neurobiology

Changes in self-reported alcohol consumption at high and low consumption in the wake of the COVID-19 pandemic: a test of the polarization hypothesis

Medication adherence in obsessive-compulsive disorders and evaluation of effective adherence support strategies

Correction: Therapeutic and legal aspects of psilocybin in cancer-related depression

A framework for safe estradiol modulation in male bipolar disorder: theoretical justification for SERM-enabled adjunctive therapy

Mindfulness, music, visual occlusion in ketamine therapy for depression: do they change outcomes? A qualitative and quantitative analysis of a randomized controlled trial

Psychedelic therapy: bridging neuroplasticity, phenomenology, and clinical outcomes

Optimizing long-acting injectable antipsychotic safety and care continuity through documentation best practices

Case Report: Clinical pharmacist prescriber in depression treatment in primary care settings: clinical case focused on prescribing practice

Pharmacist-assisted implementation of guideline recommendations for QTc monitoring during psychopharmacotherapy - a prospective, randomized feasibility study

Psychedelic minimalism: the case against music in psychedelic therapy settings

Post marketing safety assessment of the novel postpartum depression drug, Zuranolone: evidence from real-world pharmacovigilance analysis based on the FDA adverse event reporting system

Better treatment outcomes with aripiprazole long-acting injection in community and incarcerated patients with serious mental illness

New and emerging pharmacologic treatments for MDD

Effects of adjunctive brexpiprazole in patients with major depressive disorder and sleep disturbance: a post hoc analysis of three randomized trials

Improved mental health outcomes and normalised spontaneous EEG activity in veterans reporting a history of traumatic brain injuries following participation in a psilocybin retreat

Successful treatment of PGAD/GPD with leuprolide: a case report

Therapeutic and legal aspects of psilocybin in cancer-related depression

The impact of ketamine on cognitive outcomes in geriatric anesthesia: a comprehensive review

Exploration of current situation of psychotropic drugs research and development in China based on drug clinical trials

Clomipramine potentially induced fatal torsades de pointes in a patient with acute decompensated heart failure: a case report

Case Report: I want more olanzapine: pharmacogenetic insights into a patient's preference for high-dose olanzapine